Home

30 years of drug discovery experience:  Malcolm MacCoss, Ph.D., FRSC, Founder and Member of Bohicket Pharma Consulting LLC

             

              
              Bohicket Marina at sunset
        
         Dr. Malcolm MacCoss, FRSC
With 30 years of drug discovery experience in the pharmaceutical industry, Dr. MacCoss is an international expert in medicinal chemistry and in drug design and synthesis.  He is a co-discoverer of EMEND™ (aprepitant; the only orally active, FDA approved Substance P antagonist for the prevention of chemotherapy induced nausea and vomiting, and of post-operative nausea and vomiting), IVEMEND™ (fosaprepitant; a novel i.v. prodrug of aprepitant), and of JANUVIA™ (sitagliptin; the first FDA approved DPP-IV inhibitor for the treatment of type II diabetes mellitus).  JANUVIA™ is also a component of JANUMET™ (a single pill fixed dose combination of sitagliptin and metformin).